Albumin-bound paclitaxel in solid tumors: clinical development and future directionsMadappa N. Kundranda, Jiaxin Niu|Drug Design Development and Therapy|2015Cited by 253
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyJames J. Harding, Sebastián Mondaca, Jin Won Kim et al.|The Lancet Oncology|2023Cited by 243